Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

Although the currently available antidepressants are well established in the treatment of the major depressive disorder (MDD), there is strong variability in the response of individual patients. Reliable predictors to guide treatment decisions before or in an early stage of treatment are needed. DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelmann, J., Zillich, L., Frank, J., Wagner, S., Cetin, M., Herzog, D. P., Müller, M. B., Tadic, A., Foo, J. C., Sirignano, L., Braus, D. F., Dahmen, N., Sordon, S., Riemenschneider, M., Spaniol, C., Gasparoni, G., Rietschel, M., Witt, S. H., Lieb, K., Streit, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259740/
https://www.ncbi.nlm.nih.gov/pubmed/35794104
http://dx.doi.org/10.1038/s41398-022-02032-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259740/
https://www.ncbi.nlm.nih.gov/pubmed/35794104
http://dx.doi.org/10.1038/s41398-022-02032-7

Ejemplares similares